Discovery of Novel and Selective GPR17 Antagonists as Pharmacological Tools for Developing New Therapeutic Strategies in Diabetes and Obesity

GPCR Target: 1321N1 GPR17 stable cell line (Catalog# Cr1525–3)

Authors: Zhu, H., et al.

Journal: European Journal of Medicinal Chemistry, Volume 295, 2025, 117794, doi: 10.1016/j.ejmech.2025.117794